DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

Oncology Homepage

First proton therapy system arrives in South of England Second to be installed in the UK

Varian to acquire humediQ Global Bringing IDENTIFY automated workflow solution to surface-guided radiation therapy

Dr. Benjamin Movsas Society of Chairs of Academic Radiation Oncology Programs elects president

FDA clears IsoRay's and GT's cesium-131 based brachytherapy Performed during surgery to remove brain tumor, reduces follow-ups

Onkos Surgical and Insight Medical partner to bring augmented reality to tumor surgery Could this become the new standard of care?

Combined radionuclide therapy and immunotherapy shows promise New research unveiled at SNMMI meeting

Andrew J. Evans and Erik P. Sulman NYU Langone Health hires nationally renowned radiation oncologists

RaySearch releases RayStation 8A Offers greater support for radiation, proton and carbon ion therapies

Radiotherapy IT company CruxQS acquires RDS Will expand footprint for FlowBoard workflow management system

New model boosts flow efficiency of particle accelerators May lead to smaller accelerators, easier to operate at reduced costs

TomoTherapy from Accuray

Accuray’s TomoTherapy more effective than Varian’s RapidArc, non-randomized study finds

by Lisa Chamoff , Contributing Reporter
A prospective study out of France has found that intensity-modulated radiation therapy (IMRT) using helical tomotherapy delivered with Accuray’s TomoTherapy System was more effective and produced fewer side effects in head and neck cancer patients than volumetric-modulated arc therapy, using Varian’s RapidArc radiotherapy technology.

The study, published in the International Journal of Radiation Oncology * Biology * Physics and funded by the French National Institute of Cancer, was conducted at 14 French centers between February 2010 and February 2012, and included 166 patients, 74 of which were treated using the TomoTherapy System and 92 who were treated using RapidArc.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



The locoregional control rate, or local control without any nodal recurrence, after 18 months was significantly better in the TomoTherapy patient group, at 83.3 percent, than in the RapidArc group, at 72.7 percent.

The cancer specific survival rate and post-treatment salivary gland function were also better in the TomoTherapy group.

The study’s lead author, Dr. Jean-Emmanuel Bibault, a radiation oncologist at Georges-Pompidou European Hospital in Paris, said that after performing a cost analysis of TomoTherapy and volumetric-modulated arc therapy — both forms of IMRT and considered the standard of care for head and neck cancer radiotherapy — and finding that TomoTherapy is more expensive, they decided to see if the difference in cost translated into any benefit for patients.

“We must admit that we did not expect these results, because TomoTherapy and RapidArc are considered very similar,” Bibault told HCB News. “But we actually showed in our prospective study that TomoTherapy did better for local control, with less side effects. We had already showed that TomoTherapy gave more homogeneous treatment than RapidArc, and this could be one of the explanations for this difference.”

Bibault stressed that the results should be further explored in a randomized trial. A randomized trial was not possible this time due to the availability of the equipment.

“We don't have any plans for a randomized study because they are very expensive and hard to perform in radiation oncology, because most of the time, a treatment center doesn't have a TomoTherapy and a RapidArc, but we certainly think this kind of study would be very interesting,” Bibault said. “Until a randomized trial compares these two techniques, I don't think it will change practice. However, this study is a worldwide first and raises the question of the importance of the way we perform IMRT.”
  Pages: 1 - 2 >>

Oncology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED